Literature DB >> 36261616

Clinical efficacy of Er:YAG laser application in pulpotomy of primary molars: a 2-year follow-up study.

Junhui Wang1, Yujiang Chen1, Baize Zhang1, Xin Ge2, Xiaojing Wang3.   

Abstract

The present study aimed to analyze the clinical effects of Er:YAG laser applied in pulpotomy of children's asymptomatic deep caries-affected primary molars. Included primary molar teeth from children (aged 3 ~ 6 years) were randomly assigned to "Er:YAG laser" and "conventional" groups, and pulpotomies were performed under general anesthesia using the respective approaches. The treatment time and clinical efficacy were evaluated. The study sample included 100 primary molar teeth of 40 children with an average age of 4.60 ± 1.02 years. The pulpotomy time in the Er:YAG laser group was significantly longer than that in the conventional group (p < 0.0001) but the hemostasis time and the total treatment time were significantly shorter (p < 0.0001, p = 0.029). In terms of clinical efficacy, up to 6 months after treatment, the success rate in the Er:YAG laser group was non-significantly but slightly higher than that in the conventional group (100% versus 98%, p = 0.436). With longer observation time, the success rate of both groups declined, with the conventional group showing a more rapid decline. After 24 months, the success rate in the Er:YAG laser group remained non-significantly higher than that in the conventional group (89.58% versus 82.98%, p = 0.386). Overall, Er:YAG laser significantly reduced the treatment time for pulpotomy in primary teeth and tended to produce higher clinical efficacy over time and thus can be a valuable tool in clinical pediatric dentistry practice.
© 2022. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Asymptomatic deep caries-affected teeth; Er:YAG laser; Primary teeth; Pulpotomy

Year:  2022        PMID: 36261616     DOI: 10.1007/s10103-022-03655-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   2.555


  26 in total

1.  Biocompatibility and immunohistochemical evaluation of a new calcium silicate-based cement, Bio-C Pulpo.

Authors:  L Cosme-Silva; J E Gomes-Filho; F Benetti; R Dal-Fabbro; V T Sakai; L T A Cintra; E Ervolino; N V Viola
Journal:  Int Endod J       Date:  2019-01-03       Impact factor: 5.264

2.  Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.

Authors:  C Cuadros-Fernández; A I Lorente Rodríguez; S Sáez-Martínez; J García-Binimelis; I About; M Mercadé
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

Review 3.  Laser applications in endodontics: an update review.

Authors:  Zahed Mohammadi
Journal:  Int Dent J       Date:  2009-02       Impact factor: 2.512

4.  Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.

Authors:  P Juneja; S Kulkarni
Journal:  Eur Arch Paediatr Dent       Date:  2017-08-05

5.  Efficacy of three different pulpotomy agents in primary molars: a randomized control trial.

Authors:  S Rajasekharan; L C Martens; J Vandenbulcke; W Jacquet; P Bottenberg; R G E C Cauwels
Journal:  Int Endod J       Date:  2016-03-06       Impact factor: 5.264

6.  Determining treatibility of primary teeth with pulpal exposure.

Authors:  S Doğan; L Durutürk; A I Orhan; I Batmaz
Journal:  J Clin Pediatr Dent       Date:  2013       Impact factor: 1.065

7.  Clinical Pulpotomy Trial of Copaifera Langsdorffii Oil Resin Versus Formocresol and White Mineral Trioxide Aggregate in Primary Teeth.

Authors:  Prasad K Musale; Abhishek S Soni
Journal:  Pediatr Dent       Date:  2016 Mar-Apr       Impact factor: 1.874

8.  Clinical, Radiographic and Histological Evaluation of Primary Teeth Pulpotomy Using MTA And Ferric Sulfate.

Authors:  Marina Azevedo Junqueira; Nayara Nery Oliveira Cunha; Fernanda Ferreira Caixeta; Nádia Carolina Teixeira Marques; Thais Marchini Oliveira; Ana Beatriz da Silveira Moretti; Leopoldo Cosme-Silva; Vivien Thiemy Sakai
Journal:  Braz Dent J       Date:  2018 Mar-Apr

9.  Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth.

Authors:  Bharti Kusum; Kumar Rakesh; Khanna Richa
Journal:  Restor Dent Endod       Date:  2015-09-09

10.  Effects of mineral trioxide aggregate, BiodentineTM and calcium hydroxide on viability, proliferation, migration and differentiation of stem cells from human exfoliated deciduous teeth.

Authors:  Leandro Borges Araújo; Leopoldo Cosme-Silva; Ana Paula Fernandes; Thais Marchini de Oliveira; Bruno das Neves Cavalcanti; João Eduardo Gomes Filho; Vivien Thiemy Sakai
Journal:  J Appl Oral Sci       Date:  2018-02-01       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.